Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Trastuzumab,Breast cancer-treatment beyond disease progression,Trastuzumab (Herceptin),Recommended for decline,Hospital,Oncology Agents and Immunosuppressants
